Re: Confidentiality AgreementNovo Nordisk a S • November 24th, 2021 • Pharmaceutical preparations
Company FiledNovember 24th, 2021 IndustryNovo Nordisk (referred to herein as “you or your”) has requested certain Evaluation Material (as defined below) from Dicerna Pharmaceuticals, Inc. (together with its subsidiaries, the “Company”) in connection with the evaluation, negotiation or completion of a potential negotiated transaction between you and the Company (the “Potential Transaction”). You and the Company are each individually referred to in this agreement (this “Agreement”) individually as a “Party” and, collectively, as the “Parties.”
October 27, 2021Delaware • November 22nd, 2021
Jurisdiction FiledNovember 22nd, 2021